S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Compass Therapeutics (CMPX) Insider Trading & Ownership

$1.49
-0.04 (-2.61%)
(As of 04/18/2024 ET)

Compass Therapeutics (NASDAQ:CMPX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
30.00%
Number Of
Insiders Buying
(Last 3 Years)
3
Amount Of
Insider Buying
(Last 3 Years)
$21.36 M
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$62,561.23
Get CMPX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Compass Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CMPX Insider Buying and Selling by Quarter

Compass Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/10/2023Thomas J SchuetzCEOBuy10,000$3.37$33,700.00  
2/27/2023Thomas J SchuetzCEOBuy20,000$3.98$79,600.00  
2/15/2023Thomas J SchuetzCEOBuy20,000$3.86$77,200.00  
1/31/2023Thomas J SchuetzCEOBuy20,000$4.05$81,000.00  
1/24/2023Thomas J SchuetzCEOBuy20,000$4.19$83,800.00  
11/25/2022Vered Bisker-LeibCOOSell2$4.36$8.72  
11/22/2022Vered Bisker-LeibCOOSell14,929$4.19$62,552.51  
11/8/2022Orbimed Advisors LlcDirectorBuy402,000$3.21$1,290,420.00  
9/28/2022Thomas J SchuetzCEOBuy10,000$2.32$23,200.00  
9/26/2022Thomas J SchuetzCEOBuy15,000$2.27$34,050.00  
8/10/2022Thomas J SchuetzCEOBuy15,000$2.64$39,600.00  
8/1/2022Thomas J SchuetzCEOBuy15,000$2.58$38,700.00  
6/21/2022Thomas J SchuetzCEOBuy20,000$2.80$56,000.00  
6/16/2022Thomas J SchuetzCEOBuy20,000$2.34$46,800.00  
6/13/2022Thomas J SchuetzCEOBuy30,000$2.29$68,700.00  
6/6/2022Thomas J SchuetzCEOBuy30,000$2.83$84,900.00  
6/1/2022Thomas J SchuetzCEOBuy20,000$3.03$60,600.00  
5/26/2022Thomas J SchuetzCEOBuy20,000$3.04$60,800.00  
5/23/2022Thomas J SchuetzCEOBuy18,355$2.72$49,925.60  
5/13/2022Carl L GordonDirectorBuy30,722$2.49$76,497.78  
5/11/2022Carl L GordonDirectorBuy64,700$1.79$115,813.00  
5/10/2022Thomas J SchuetzCEOBuy27,836$1.80$50,104.80  
5/9/2022Orbimed Advisors LlcDirectorBuy90,712$1.56$141,510.72  
5/6/2022Orbimed Advisors LlcDirectorBuy10,200$1.63$16,626.00  
11/4/2021Carl L GordonDirectorBuy5,357,143$3.50$18,750,000.50  
(Data available from 1/1/2013 forward)

CMPX Insider Trading Activity - Frequently Asked Questions

Who is on Compass Therapeutics's Insider Roster?

The list of insiders at Compass Therapeutics includes Carl L Gordon, Orbimed Advisors Llc, Thomas J Schuetz, and Vered Bisker-Leib. Learn more on insiders at CMPX.

What percentage of Compass Therapeutics stock is owned by insiders?

30.00% of Compass Therapeutics stock is owned by insiders. Learn more on CMPX's insider holdings.

Which Compass Therapeutics insiders have been buying company stock?

The following insiders have purchased CMPX shares in the last 24 months: Carl L Gordon ($192,310.78), Orbimed Advisors Llc ($1,448,556.72), and Thomas J Schuetz ($968,680.40).

How much insider buying is happening at Compass Therapeutics?

Insiders have purchased a total of 929,525 CMPX shares in the last 24 months for a total of $2,609,547.90 bought.

Which Compass Therapeutics insiders have been selling company stock?

The following insider sold CMPX shares in the last 24 months: Vered Bisker-Leib ($62,561.23).

How much insider selling is happening at Compass Therapeutics?

Insiders have sold a total of 14,931 Compass Therapeutics shares in the last 24 months for a total of $62,561.23 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:CMPX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners